Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Learn which credit card offers the best rewards for travel to make your journeys even more enjoyable. Explore options now.
26,760 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
A decade-long income lure from QYLD masks a sizable NAV erosion. The ETF's NAV has declined about 35% since its 2013 ...
A small-business owner in upstate New York is turning stickers into a political platform, blending merchandise with a...
Volkswagen signals a smarter-cost strategy to turn around its performance, prioritizing efficiency over plant shutdow...
Dragonfly Capital closes a $650 million fund to back early-stage crypto ventures as liquidity tightens and token pric...
Novo Nordisk has faced headwinds, but a new GLP-1 drug could change the game. This article breaks down what investors...
In just one year, Nebius Group has moved from curiosity to a marquee name in AI infrastructure. This piece unpacks wh...
Rising buzz that Elon Musk could reach trillionaire status clashes with Tesla's 2026 stock slump. This report breaks ...
Verizon stock has trended flat lately, but July 24 earnings could spark movement. This guide breaks down whether shou...
Meta Platforms is negotiating a landmark AI hardware pact with AMD that could top $100 billion, including an option f...
Mission Produce enters 2026 with a mix of hedges, growing demand, and a tight supply chain. This guide breaks down wh...
A wave of AI compute demand is reshaping the chip landscape. While Cerebras eyes an IPO, the market shows that strong...